{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-16T12:20:53.032036+00:00",
  "news": [
    {
      "title": "Amgen’s Sotorasib Study Update: Expanded Access for NSCLC Patients - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPZ24yMjNxRE0yb0FBb1BSRy1GSVJhLXoyWHY2b2ROUDJQOHctRFhWOVNnT0hBbk9jMDViU2ZWMXU3eUdrRGZlcV9YTWZpLUJ3X1NYa0o5a1pLaUw5Y2Vva25JQldadmNIVU5Gb1kxc0c0ekltVlA4aGtvSm1jeVlvSHNBT2hFLUhmN1VpT0dYcV9fVUxBUHZ1VVJaelE4TGx1a3RqQjNuTlQzYmdBQUswemxfc1V5czg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZ24yMjNxRE0yb0FBb1BSRy1GSVJhLXoyWHY2b2ROUDJQOHctRFhWOVNnT0hBbk9jMDViU2ZWMXU3eUdrRGZlcV9YTWZpLUJ3X1NYa0o5a1pLaUw5Y2Vva25JQldadmNIVU5Gb1kxc0c0ekltVlA4aGtvSm1jeVlvSHNBT2hFLUhmN1VpT0dYcV9fVUxBUHZ1VVJaelE4TGx1a3RqQjNuTlQzYmdBQUswemxfc1V5czg?oc=5\" target=\"_blank\">Amgen’s Sotorasib Study Update: Expanded Access for NSCLC Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-16T05:47:46+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Stock Analysis | Amgen Outlook - A Neutral Technical Picture Amid Mixed Analyst Ratings and Positive Fund Flows - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQM0p0aTQzUEN3TFpmRGRsSWpQRzlnS2YxSU5VZUtNZVFVNHlycHVWNFJ5MUQ2Tk5nUnZIbkg1NVRSdGxHY2RYWFJMRDlGYW1NMkVtb2liRHBkX2ItY2VaNzdxN0hUUHpFVFM2Q3FNYnpQNkhNWjZYOGttSUo2TmVXLTJscmplRFRVajREZHdjRWJfWGV2Q1BvWjFZMGRTU3p5SWx6dm1ZLXVOTU9hWnp4WTgzbFYtTHN5eTBaMHV1YnRwWGEydDB2OUVZQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQM0p0aTQzUEN3TFpmRGRsSWpQRzlnS2YxSU5VZUtNZVFVNHlycHVWNFJ5MUQ2Tk5nUnZIbkg1NVRSdGxHY2RYWFJMRDlGYW1NMkVtb2liRHBkX2ItY2VaNzdxN0hUUHpFVFM2Q3FNYnpQNkhNWjZYOGttSUo2TmVXLTJscmplRFRVajREZHdjRWJfWGV2Q1BvWjFZMGRTU3p5SWx6dm1ZLXVOTU9hWnp4WTgzbFYtTHN5eTBaMHV1YnRwWGEydDB2OUVZQQ?oc=5\" target=\"_blank\">Stock Analysis | Amgen Outlook - A Neutral Technical Picture Amid Mixed Analyst Ratings and Positive Fund Flows</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-16T06:51:53+00:00",
      "source": "AInvest"
    },
    {
      "title": "Resona Asset Management Co. Ltd. Buys 13,390 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPM0RPbjd3bk84NGRRY1VhaTBGNFdFbGRkUWZTcHp6RFAwOVNNQThvbGdBQTYyTGk1amNsNHkycTQ2MGd0TmUzaTJGZi1pUW1NSDJmdkYyTHZFSXVnc04wd0FPeURPb2NGaWxXbXVndTM4V2U2cTZNekxmYS1XT2VMcTRDZnhlVVhxWWdfeEN6SC1uNHBXdF9mZHlYbkRGNHhpVFU5ZUljWGVHS3hGSEpTejc1WFpxV0RKZzF2cERYX1VVN1BSR05MaWhsQ2Jwdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxPM0RPbjd3bk84NGRRY1VhaTBGNFdFbGRkUWZTcHp6RFAwOVNNQThvbGdBQTYyTGk1amNsNHkycTQ2MGd0TmUzaTJGZi1pUW1NSDJmdkYyTHZFSXVnc04wd0FPeURPb2NGaWxXbXVndTM4V2U2cTZNekxmYS1XT2VMcTRDZnhlVVhxWWdfeEN6SC1uNHBXdF9mZHlYbkRGNHhpVFU5ZUljWGVHS3hGSEpTejc1WFpxV0RKZzF2cERYX1VVN1BSR05MaWhsQ2Jwdw?oc=5\" target=\"_blank\">Resona Asset Management Co. Ltd. Buys 13,390 Shares of Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-16T01:59:21+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNY1JqYkV1RlVQNVFDZ2tyaFhoXy1qcEtmM1NlZnhoeWVvV2pMUlZ4ZklFbEVJRFVHbC1uZzZoM0RVQmlyOTFJQzdJNV82clo4TDJiNTZWZ0FwSXJpV1k5VmI4anRpc1lMVUJ4Z0Rib09NMDRlaEs3ZFJSNTRBalEwTWExdUtpWF9VZ3ktZlg5SXlOeTM2TGpFSHZGak1VNW8?oc=5\" target=\"_blank\">Amgen skirts $50M payout in Blincyto patent litigation tiff with Lindis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-15T14:13:20+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5\" target=\"_blank\">US judge overturns Amgen's $50.3 mln loss in cancer drug patent case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-14T19:28:47+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOQ3R0OFR1T18zOVFlMC1YTl8tZ2s5S2c5WVdHT25DRFhZQnF1VzQwVGd5Z2hJS3FWUExTSGc0dWoyc2ZWSVo1eF9GNG9DVFZlNjdPLWt3SUIxQjktMXRRcURtR25xSG5VbXY1QXJsOGhaUGpUZmp1VHcwUWFYRE5uclZzMFVrOUpMdTJ3SGU1Y0pNdWFLc2dB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOQ3R0OFR1T18zOVFlMC1YTl8tZ2s5S2c5WVdHT25DRFhZQnF1VzQwVGd5Z2hJS3FWUExTSGc0dWoyc2ZWSVo1eF9GNG9DVFZlNjdPLWt3SUIxQjktMXRRcURtR25xSG5VbXY1QXJsOGhaUGpUZmp1VHcwUWFYRE5uclZzMFVrOUpMdTJ3SGU1Y0pNdWFLc2dB?oc=5\" target=\"_blank\">Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-12T00:24:18+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Medidata elevates Amgen vet to lead business strategy - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMXFpWjlYVGJjcVpzNURONkpEOW14RnNORjhuVjlGaVJYVGxRdXB1aVlzMkpocS1sTDRvc3RnT0NwQXBfVTNwb1lKWWpsS0czVlNhMzV5Nm9ZQ094RGh0VnphTUw4TjdXdWlUQW83ZzZTMEJ0cjRRR2h5cHRjemJteHkxbktMVW5LaXVUZ3pCSHozN2s5S3lNY1BVSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMXFpWjlYVGJjcVpzNURONkpEOW14RnNORjhuVjlGaVJYVGxRdXB1aVlzMkpocS1sTDRvc3RnT0NwQXBfVTNwb1lKWWpsS0czVlNhMzV5Nm9ZQ094RGh0VnphTUw4TjdXdWlUQW83ZzZTMEJ0cjRRR2h5cHRjemJteHkxbktMVW5LaXVUZ3pCSHozN2s5S3lNY1BVSQ?oc=5\" target=\"_blank\">Medidata elevates Amgen vet to lead business strategy</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-08-13T16:15:10+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen’s Pediatric SHPT Study: A Potential Game-Changer for Etelcalcetide - MSN",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPa1JCanZvZk54S2F6Vm1QcDh1RVdsaE04Q2V4eW1ibHBkbnJvTkY1TE12eWM1eXpXaUpyTmg5NE16eDVxOVBBUTFYd21iQWpZdTBFbF9NdjVGSUV5aGdySjZ5ZWFvWWQ3STk1VVoyZUZOcXdpbzk1NGhlMDZtOFR0Y0p2R0ZOZ1pFaHlWTUhEel9XZXRnNDBMVS0zODZWTU1leU5hLTV4dy11UkJHZjhmaXFTU3FDRnVoTF9FbTRtYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPa1JCanZvZk54S2F6Vm1QcDh1RVdsaE04Q2V4eW1ibHBkbnJvTkY1TE12eWM1eXpXaUpyTmg5NE16eDVxOVBBUTFYd21iQWpZdTBFbF9NdjVGSUV5aGdySjZ5ZWFvWWQ3STk1VVoyZUZOcXdpbzk1NGhlMDZtOFR0Y0p2R0ZOZ1pFaHlWTUhEel9XZXRnNDBMVS0zODZWTU1leU5hLTV4dy11UkJHZjhmaXFTU3FDRnVoTF9FbTRtYw?oc=5\" target=\"_blank\">Amgen’s Pediatric SHPT Study: A Potential Game-Changer for Etelcalcetide</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-08-14T09:59:33+00:00",
      "source": "MSN"
    }
  ],
  "product_launches": [
    {
      "title": "Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva - koreabiomed.com",
      "link": "https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5\" target=\"_blank\">Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">koreabiomed.com</font>",
      "published": "2025-08-04T01:50:03+00:00",
      "source": "koreabiomed.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-15",
      "close": 296.4700012207031
    },
    "history": [
      {
        "date": "2025-08-07",
        "close": 284.70001220703125
      },
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      },
      {
        "date": "2025-08-11",
        "close": 285.0899963378906
      },
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      },
      {
        "date": "2025-08-13",
        "close": 289.3299865722656
      },
      {
        "date": "2025-08-14",
        "close": 290.2900085449219
      },
      {
        "date": "2025-08-15",
        "close": 296.4700012207031
      }
    ],
    "name": "Amgen Inc."
  }
}